Sciety

Neutralizing Antibodies Isolated by a site-directed Screening have Potent Protection on SARS-CoV-2 Infection

This article has 10 authors:
1. Xiaoyu Liu
2. Fang Gao
3. Liming Gou
4. Yin Chen
5. Yayun Gu
6. Lei Ao
7. Hongbing Shen
8. Zhibin Hu
9. Xiling Guo
10. Wei Gao
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version May 3, 2020Latest activity Jun 6, 2020
Estimating the cumulative incidence of SARS-CoV-2 with imperfect serological tests: Exploiting cutoff-free approaches

This article has 4 authors:
1. Judith A. Bouman
2. Julien Riou
3. Sebastian Bonhoeffer
4. Roland R. Regoes
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Feb 26, 2021Latest activity Jun 6, 2020
Validation of a SARS-CoV-2 spike protein ELISA for use in contact investigations and sero-surveillance

This article has 18 authors:
1. Brandi Freeman
2. Sandra Lester
3. Lisa Mills
4. Mohammad Ata Ur Rasheed
5. Stefany Moye
6. Olubukola Abiona
7. Geoffrey B. Hutchinson
8. Maria Morales-Betoulle
9. Inna Krapinunaya
10. Ardith Gibbons
11. Cheng-Feng Chiang
12. Deborah Cannon
13. John Klena
14. Jeffrey A. Johnson
15. Sherry Michele Owen
16. Barney S. Graham
17. Kizzmekia S. Corbett
18. Natalie J. Thornburg
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Apr 24, 2020Latest activity Jun 6, 2020
Recombinant SARS-CoV-2 spike S1-Fc fusion protein induced high levels of neutralizing responses in nonhuman primates

This article has 24 authors:
1. Wenlin Ren
2. Hunter Sun
3. George F. Gao
4. Jianxin Chen
5. Sean Sun
6. Rongqing Zhao
7. Guang Gao
8. Yalin Hu
9. Gan Zhao
10. Yuxin Chen
11. Xia Jin
12. Feng Fang
13. Jinggong Chen
14. Qi Wang
15. Sitao Gong
16. Wen Gao
17. Yufei Sun
18. Junchi Su
19. Ailiang He
20. Xin Cheng
21. Min Li
22. Chenxi Xia
23. Maohua Li
24. Le Sun
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Jul 1, 2020Latest activity Jun 6, 2020
This article has 4 authors:
1. Zahra Yazdani
2. Alireza Rafiei
3. Mohammadreza Yazdani
4. Reza Valadan
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Aug 1, 2020Latest activity Jun 6, 2020
Regulation of Angiotensin- Converting Enzyme 2 in Obesity: Implications for COVID-19

This article has 8 authors:
1. Saba Al Heialy
2. Mahmood Yaseen Hachim
3. Abiola Senok
4. Mellissa Gaudet
5. Ahmad Abou Tayoun
6. Rifat Hamoudi
7. Alawi Alsheikh-Ali
8. Qutayba Hamid
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Sep 18, 2020Latest activity Jun 6, 2020
Analysis of SARS-CoV-2 antibodies in COVID-19 convalescent blood using a coronavirus antigen microarray

This article has 27 authors:
1. Rafael R. de Assis
2. Aarti Jain
3. Rie Nakajima
4. Algis Jasinskas
5. Jiin Felgner
6. Joshua M. Obiero
7. Philip J. Norris
8. Mars Stone
9. Graham Simmons
10. Anil Bagri
11. Johannes Irsch
12. Martin Schreiber
13. Andreas Buser
14. Andreas Holbro
15. Manuel Battegay
16. Philip Hosimer
17. Charles Noesen
18. Oluwasanmi Adenaiye
19. Sheldon Tai
20. Filbert Hong
21. Donald K. Milton
22. D. Huw Davies
23. Paul Contestable
24. Laurence M. Corash
25. Michael P. Busch
26. Philip L. Felgner
27. Saahir Khan
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Jan 4, 2021Latest activity Jun 5, 2020
Genome based evolutionary lineage of SARS-CoV-2 towards the development of novel chimeric vaccine

This article has 9 authors:
1. Mst Rubaiat Nazneen Akhand
2. Kazi Faizul Azim
3. Syeda Farjana Hoque
4. Mahmuda Akther Moli
5. Bijit Das Joy
6. Hafsa Akter
7. Ibrahim Khalil Afif
8. Nadim Ahmed
9. Mahmudul Hasan
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Nov 1, 2020Latest activity Jun 5, 2020
Comparative in vitro transcriptomic analyses of COVID-19 candidate therapy hydroxychloroquine suggest limited immunomodulatory evidence of SARS-CoV-2 host response genes

This article has 5 authors:
1. Michael J. Corley
2. Christopher Sugai
3. Michael Schotsaert
4. Robert E. Schwartz
5. Lishomwa C. Ndhlovu
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Apr 14, 2020Latest activity Jun 5, 2020
De novo design and Rosetta‐based assessment of high‐affinity antibody variable regions (Fv) against the SARS‐CoV ‐2 spike receptor binding domain ( RBD )

This article has 7 authors:
1. Veda Sheersh Boorla
2. Ratul Chowdhury
3. Ranjani Ramasubramanian
4. Brandon Ameglio
5. Rahel Frick
6. Jeffrey J. Gray
7. Costas D. Maranas
Reviewed by ScreenIT

This article has 1 evaluationAppears in 1 listLatest version Oct 8, 2022Latest activity Jun 5, 2020

Previous Page 39 of 171 Next

Immunology

Neutralizing Antibodies Isolated by a site-directed Screening have Potent Protection on SARS-CoV-2 Infection

Estimating the cumulative incidence of SARS-CoV-2 with imperfect serological tests: Exploiting cutoff-free approaches

Validation of a SARS-CoV-2 spike protein ELISA for use in contact investigations and sero-surveillance

Recombinant SARS-CoV-2 spike S1-Fc fusion protein induced high levels of neutralizing responses in nonhuman primates

Regulation of Angiotensin- Converting Enzyme 2 in Obesity: Implications for COVID-19

Analysis of SARS-CoV-2 antibodies in COVID-19 convalescent blood using a coronavirus antigen microarray

Genome based evolutionary lineage of SARS-CoV-2 towards the development of novel chimeric vaccine

Comparative in vitro transcriptomic analyses of COVID-19 candidate therapy hydroxychloroquine suggest limited immunomodulatory evidence of SARS-CoV-2 host response genes

De novo design and Rosetta‐based assessment of high‐affinity antibody variable regions (Fv) against the SARS‐CoV ‐2 spike receptor binding domain ( RBD )